Diagnostischer Standard bei chronisch entzündlichen Darmerkrankungen

C. Ell,M. Raithel

DOI: https://doi.org/10.1007/s001080050272

1998-10-01

Der Internist

Abstract:

What problem does this paper attempt to address?

Narrative review-diagnosing and managing malignant epidural spinal cord compression: an evidence-based approach

Zarique Z Akanda,Michael J McKay

DOI: https://doi.org/10.21037/atm-22-3076

2023-10-25

Abstract:Background and objective: Malignant spinal cord compression (MSCC) is a medical emergency. Clinical deterioration can occur quickly and irreversibly. MSCC is caused predominantly by metastatic cancer spread to the epidural space by epithelial or haematological malignancies. The primary diagnostic test is full-spine magnetic resonance imaging (MRI) since it has excellent soft tissue spatial resolution, and MSCC is multi-level in around one-third of cases. The modalities of therapy for MSCC are steroids, radiotherapy, and surgery. Radiotherapy is a mainstay of treatment since indications for surgery are limited. Recently randomised clinical trials exploring long course vs. short course radiotherapy have been undertaken as well as novel incorporation of stereotactic ablative radiotherapy (SABR). This review summarises these recent trials and identifies and discusses published data for novel treatment paradigms of MSCC. Methods: Multiple medical databases were searched through January 7th, 2023 and identified relevant studies that examined the use of radiotherapy with or without surgery in the management of MSCC. Key content and findings: In addition to a detailed overview of the pathophysiology and diagnosis of cord compression, we also examine all recent phase III clinical trials to date on the use of conventional radiotherapy in managing MSCC. Our review also provides a comprehensive summary and discussion of the novel approaches to the management of cord compression, including the role of SABR and a non-traditional surgical approach as well. Conclusions: Shorter courses of radiotherapy can be considered for poor prognosis patients. For favourable prognosis patients, longer courses of treatment provide more durable local control. An emerging treatment paradigm is a hybrid approach of surgery and SABR, however this has not been studied prospectively.
Non-gravitational forces and masses of some long-period comets. The cases of Hale-Bopp and Hyakutake

A. Sosa,Julio A. Fernández

DOI: https://doi.org/10.1017/S1743921310001547

2009-08-01

Proceedings of the International Astronomical Union

Abstract:Abstract By means of a simple non-gravitational force model of the cometary nucleus, which relies on the observed light curves assumed to be a good representation of the water sublimation rate, we estimate the masses of a sample of long-period comets (LPCs). A critical issue of our method is the assumption of a correlation between visual heliocentric magnitudes and water production rates. This is a necessary assumption because of the sparse observational data of gas production rates (with the exception of very few comets like Hale-Bopp or Hyakutake). In this regard we present here a new correlation for LPCs. We also present the preliminary results for the masses of comets Hale-Bopp and Hyakutake.
Advances in Imaging for Metastatic Epidural Spinal Cord Compression: A Comprehensive Review of Detection, Diagnosis, and Treatment Planning

Paschyanti R Kasat,Shivali V Kashikar,Pratapsingh Parihar,Pratiksha Sachani,Priyal Shrivastava,Smruti A Mapari,Utkarsh Pradeep,Gautam N Bedi,Paritosh N Bhangale

DOI: https://doi.org/10.7759/cureus.70110

2024-09-24

Cureus

Abstract:Metastatic epidural spinal cord compression (MESCC) is a critical oncologic emergency caused by the invasion of metastatic tumors into the spinal epidural space, leading to compression of the spinal cord. If not promptly diagnosed and treated, MESCC can result in irreversible neurological deficits, including paralysis, significantly impacting the patient's quality of life. Early detection and timely intervention are crucial to prevent permanent damage. Imaging modalities play a pivotal role in the diagnosis, assessment of disease extent, and treatment planning for MESCC. Magnetic resonance imaging (MRI) is the current gold standard due to its superior ability to visualize the spinal cord, epidural space, and metastatic lesions. However, recent advances in imaging technologies have enhanced the detection and management of MESCC. Innovations such as functional MRI, diffusion-weighted imaging (DWI), and hybrid techniques like positron emission tomography-computed tomography (PET-CT) and PET-MRI have improved the accuracy of diagnosis, particularly in detecting early metastatic changes and guiding therapeutic interventions. This review provides a comprehensive analysis of the evolution of imaging techniques for MESCC, focusing on their roles in detection, diagnosis, and treatment planning. It also discusses the impact of these advances on clinical outcomes and future research directions in imaging modalities for MESCC. Understanding these advancements is critical for optimizing the management of MESCC and improving patient prognosis.
Surgical Management and Outcomes of Spinal Metastasis of Malignant Adrenal Tumor: A Retrospective Study of Six Cases and Literature Review

Xiangzhi Ni,Jing Wang,Jiashi Cao,Kun Zhang,Shuming Hou,Xing Huang,Yuanjin Song,Xin Gao,Jianru Xiao,Tielong Liu

DOI: https://doi.org/10.3389/fonc.2023.1110045

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:PurposeSpinal metastasis of malignant adrenal tumor (SMMAT) is an extremely rare and poorly understood malignant tumor originating from the adrenal gland. The objective of this study is to elucidate the clinical characteristics and discuss surgical management and outcomes of SMMAT. MethodsIncluded in this study were six SMMAT patients who received surgical treatment in our center between February 2013 and May 2022. Their clinical data and outcomes were retrospectively analyzed to gain a better understanding of SMMAT. In addition, ten cases from the literature focusing on SMMAT were also reviewed. ResultsSurgery was performed successfully, and the associated symptoms were relieved significantly in all patients postoperatively. The mean follow-up duration was 26.2 (range 3-55) months. Two patients died of tumor recurrence 12 and 48 months after operation respectively. The other four patients were alive at the last follow-up. ConclusionsThe prognosis of SMMAT is usually poor. Preoperative embolization and early surgical radical resection can offer satisfactory clinical outcomes. The patient's health status, preoperative neurological function, tumor location and the resection mode are potential prognostic factors of SMMAT.
Approaches to radiotherapy in metastatic spinal cord compression

Morten Hiul Suppl

Abstract:Metastatic spinal cord compression is caused by the progression of metastatic lesions within the vicinity of the spinal cord. The consequences are very severe with loss of neurological function and severe pain. The standard treatment is surgical intervention followed by radiotherapy or radiotherapy alone. However, the majority of patients are treated with radiotherapy only due to contraindications to surgery and technical inoperability. Stereotactic body radiotherapy is a technology to deliver higher radiation dose to the radiotherapy target with the use of spatial coordinates. This modality has shown positive results in treating lesions in brain and lungs. Hence, it could prove beneficial in metastatic spinal cord compression. We designed and planned a trial to investigate this method in patients with metastatic spinal cord compression. The method was usable but the trial was stopped prematurely due to low accrual that made comparison with surgery impossible. Low accrual is a known problem for trials evaluating new approaches in radiotherapy. Target definition in radiotherapy of metastatic spinal cord compression is defined by patient history, examination and imaging. Functional imaging could provide information to guide target definition with the sparring of normal tissue e.g. spinal cord and hematopoietic tissue of the bone marrow. In future trials this may be used for dose escalation of spinal metastases. The trial showed that PET/MRI was feasible in this group of patients but did not change the radiotherapy target in the included patients. Neurological outcome is similar irrespective of course length and therefore single fraction radiotherapy is recommended for the majority of patients. In-field recurrence is a risk factor of both short and long fractionation schemes and re-irradiation have the potential risk of radiation-induced myelopathy. In a retrospective study of re-irradiation, we investigated the incidence of radiation-induced myelopathy. In our study population, we found a higher number of patients experiencing vertebral fractures than the number of patient developing myelopathy. Patients with diabetes had an increased risk of toxicity compared to the remaining patients. Stereotactic body radiotherapy is effective in treating metastatic spinal cord compression but the efficacy cannot be determined due low accrual. The use of PET/MRI did not spare normal tissue in radiotherapy planning of spinal metastases. The incidence of toxicity after re-irradiation of the spine and spinal cord was low. For patients with in-field recurrence, re-irradiation is safe and has a low incidence of toxicity.
Evaluating the impact of the metastatic spinal cord compression coordinator in a regional cancer network: a prospective, non-randomized pilot study

Rubyyat-A Hakim,Joao R Galante,Huma Zahid,Mariya Karova,Tamir Sirkis,Zartaj Ahmed,Katy Taylor,Steve Dann,Woojin Chae,Archil Tsirekidze,Russell Burcombe,Charlotte Moss,Kathryn Lees,Sola Adeleke

DOI: https://doi.org/10.21037/apm-22-1102

Abstract:Background: Extradural metastatic spinal cord compression (MSCC) is a debilitating and potentially irreversible complication of cancer. Delay in treatment could lead to irreversible neurological damage, adverse quality of life and a burden on health care resources. Lack of effective communication between teams has been identified as one of the reasons for delay in treatment. The MSCC coordinator (often a nurse, radiotherapy radiographer or a doctor) is responsible for coordinating the diagnosis and management of patients with MSCC. The role has been shown to streamline service, ensure timely decision-making and improved survival outcomes. However, available data are anecdotal or from limited series presented as abstracts in conferences. In this study, we assessed the impact (time to treatment) of the newly introduced role on the treatment pathway compared to similar period in the preceding year. Methods: This was a multi-centre, prospective, pilot study carried out in Kent, UK between 1st April to 30th June 2021. Patients were considered eligible if they had magnetic resonance imaging (MRI)-confirmed cauda equina or cord compression. The data prospectively collected include: (I) time from diagnostic imaging to radiotherapy treatment; (II) number of referrals to hospital palliative care (HPC), occupational/physiotherapy (OPH) and community hospice referrals (CHP). A comparative retrospective data for (I) was collected for the same time period in the preceding year. The study outcome assessed was reduction in time from radiological diagnosis of MSCC to receiving radiotherapy. Results: Fifty-eight patients in 2020 and 24 patients in 2021 were included in the dataset. The MSCC coordinator role (introduced in 2021) led to reduction in the time from imaging to treatment (P=0.045). Compared to 2020, there was a shorter mean/median time to treatment, seeing more patients being treated within 24 hours. All hospitals except East Kent Hospitals saw more patients being treated within 24 hours. 7 referrals each made to HPC, OPH and CHP respectively. Conclusions: Introduction of MSCC coordinator role led to improved time from imaging to radiotherapy treatment. The new service led to engagement with rehabilitative and palliative services. Future work should be done to assess the long-term impact of this role on utilization of support services and patient recovery.
Challenge or opportunity: Rehabilitation outcomes in patients with metastatic spinal cord compression – a UK single center experience

Gisele Lafeuillee,Manish Desai,Francesco Magni,Sarah Knight

DOI: https://doi.org/10.1080/10790268.2022.2097997

2022-10-20

Abstract:Metastatic Spinal Cord Compression (MSCC) is a devastating complication of cancer, affecting approximately 3000 patients per annum in England. However, access to rehabilitation services for MSCC patients is limited. The London Spinal Cord Injury Centre has set up a bespoke MSCC rehabilitation pathway from May 2013. This article aims to describe the clinical features and functional outcomes of patients with MSCC admitted to a Specialist Spinal Cord Injury Rehabilitation Centre between May 2013 and December 2021. Retrospective analysis of medical records from a single specialist rehabilitation centre database. London Spinal Cord Injury Centre (LSCIC), Stanmore, United Kingdom. Adult patients diagnosed with MSCC who were admitted to and discharged from LSCIC from May 2013 to December 2021. Specialist Inpatient Spinal Cord Injury Rehabilitation Program. Spinal Cord Independence Measure 19 (SCIM version III), Discharge Destination. A total of 40 patients with MSCC were admitted – 32 male and 8 female patients. The average length of stay was 6 weeks. 17(42.5%) patients had primary prostate cancer. Most patients (34(85%)) had thoracic MSCC. There was an improvement in the Spinal Cord Independence Measure in all patients with an average significant improvement from 43.8 to 64.5 (P < 0.001). There was no significant difference in SCIM scores between patients under 65 and over 65. 28 (70%) patients required psychological input. 33(82.5%) patients were discharged home. Patients with MSCC show improvement in SCIM outcome measures after a six-week inpatient Specialist Spinal Rehabilitation program.
Surgery in Acute Metastatic Spinal Cord Compression: Timing and Functional Outcome

Hanno S Meyer,Arthur Wagner,Alessandra Raufer,Ann-Kathrin Joerger,Jens Gempt,Bernhard Meyer

DOI: https://doi.org/10.3390/cancers14092249

2022-04-30

Abstract:Background: Patients with metastatic spinal cord compression (MSCC) may experience long-term functional impairment. It has been established that surgical decompression improves neurological outcomes, but the effect of early surgery remains uncertain. Our objective was to evaluate the impact of early versus late surgery for acute MSCC due to spinal metastases (SM). Methods: We retrospectively reviewed a consecutive cohort of all patients undergoing surgery for SMs at our institution. We determined the prevalence of acute MSCC; the time between acute neurological deterioration as well as between admission and surgery (standard procedure: decompression and instrumentation); and neurological impairment graded by the ASIA scale upon presentation and discharge. Results: We screened 693 patients with surgery for spinal metastasis; 140 patients (21.7%) had acute MSCC, defined as neurological impairment corresponding to ASIA grade D or lower, acquired within 72 h before admission. Non-MSCC patients had surgery for SM-related cauda equina syndrome, radiculopathy and/or spinal instability. Most common locations of the SM in acute MSCC were the thoracic (77.9%) and cervical (10.7%) spine. Per standard of care, acute MSCC patients underwent surgery including decompression and instrumentation, and the median time from admission to surgery was 16 h (interquartile range 10-22 h). Within the group of patients with acute MSCC, those who underwent early surgery (i.e., before the median 16 h) had a significantly higher rate of ASIA improvement by at least one grade at discharge (26.5%) compared to those who had late surgery after 16 h (10.1%; p = 0.024). Except for a significantly higher sepsis rate in the late surgery group, complication rates did not differ between the late and early surgery subgroups. Conclusions: We report data on the largest cohort of patients with MSCC to date. Early surgery is pivotal in acute MSCC, substantially increasing the chance for neurological improvement without increasing complication rates. We found no significant impact when surgery was performed later than 24 h after admission. These findings will provide the framework for a much-needed prospective study. Until then, the treatment strategy should entail the earliest possible surgical intervention.
Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases

Mara Bozza Stephenson,Bryan Glaenzer,Angelo Malamis

DOI: https://doi.org/10.1007/s11864-016-0433-1

Abstract:Spinal metastases are a common and morbid condition in America. Of the 1.6 million new cases of cancer estimated to be diagnosed in the USA in 2015, approximately 5-10 % will develop spinal metastases. This number is expected to increase as the life expectancy of cancer patients increases. Patients with osteolytic spinal metastases experience severe and often debilitating pain, which significantly reduces quality of life. Due to the morbidity of open surgery, particularly in oncologic patients, the treatment paradigm has shifted towards minimally invasive therapy. The advent and evolution of percutaneous treatments of spinal metastases has shown progressive success in reducing pain, improving function, and providing mechanical stability. There are various currently available interventions including vertebroplasty, vertebral augmentation, and coblation and radiofrequency ablation systems. For more complex spinal metastases, combined treatments including vertebral augmentation in conjunction with radiofrequency ablation, external beam radiation, and the novel treatment of intraoperative radiotherapy are also available. Ultimately, the goal of treatment in this patient population is palliative with the intention of improving the remaining quality of life. There is no established algorithm or specific technique that has proved best for the many variations of vertebral compression fractures (VCFs), so treatment tends to be dependent on the operator and/or based on institution preference or bias. Each technique provides its own unique value in the various types of metastatic VCFs encountered, and understanding the uses, advantages, and safety profile of each specific treatment is imperative in providing the best patient care. Percutaneous treatment of metastatic spinal disease is an excellent alternative to medical and surgical management in carefully selected patients. We believe that a multidisciplinary approach and combination therapy allows for optimal pain reduction and improvement of function.
Diagnostic Accuracy of CT for Metastatic Epidural Spinal Cord Compression

James Thomas Patrick Decourcy Hallinan,Shuliang Ge,Lei Zhu,Wenqiao Zhang,Yi Ting Lim,Yee Liang Thian,Pooja Jagmohan,Tricia Kuah,Desmond Shi Wei Lim,Xi Zhen Low,Ee Chin Teo,Nesaretnam Barr Kumarakulasinghe,Qai Ven Yap,Yiong Huak Chan,Jiong Hao Tan,Naresh Kumar,Balamurugan A. Vellayappan,Beng Chin Ooi,Swee Tian Quek,Andrew Makmur

DOI: https://doi.org/10.3390/cancers14174231

2022-01-01

Cancers

Abstract:Background: Early diagnosis of metastatic epidural spinal cord compression (MESCC) is vital to expedite therapy and prevent paralysis. Staging CT is performed routinely in cancer patients and presents an opportunity for earlier diagnosis. Methods: This retrospective study included 123 CT scans from 101 patients who underwent spine MRI within 30 days, excluding 549 CT scans from 216 patients due to CT performed post-MRI, non-contrast CT, or a gap greater than 30 days between modalities. Reference standard MESCC gradings on CT were provided in consensus via two spine radiologists (11 and 7 years of experience) analyzing the MRI scans. CT scans were labeled using the original reports and by three radiologists (3, 13, and 14 years of experience) using dedicated CT windowing. Results: For normal/none versus low/high-grade MESCC per CT scan, all radiologists demonstrated almost perfect agreement with kappa values ranging from 0.866 (95% CI 0.787–0.945) to 0.947 (95% CI 0.899–0.995), compared to slight agreement for the reports (kappa = 0.095, 95%CI −0.098–0.287). Radiologists also showed high sensitivities ranging from 91.51 (95% CI 84.49–96.04) to 98.11 (95% CI 93.35–99.77), compared to 44.34 (95% CI 34.69–54.31) for the reports. Conclusion: Dedicated radiologist review for MESCC on CT showed high interobserver agreement and sensitivity compared to the current standard of care.
Die dynamische Pyramide zur 3D-Rekonstruktion von Bildpaaren

J. Dengler,H. Meinzer

DOI: https://doi.org/10.1007/978-3-642-70638-7_13

1985-09-24

Abstract:
Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature

Michael Kritikos,Juan Vivanco-Suarez,Nahom Teferi,Sarah Lee,Kyle Kato,Kathryn L. Eschbacher,Girish Bathla,John M. Buatti,Patrick W. Hitchon

DOI: https://doi.org/10.1007/s10143-024-02308-0

IF: 2.8

2024-02-07

Neurosurgical Review

Abstract:Intramedullary spinal cord metastasis (ISCM), though rare, represents a potentially debilitating manifestation of systemic cancer. With emerging advances in cancer care, ISCMs are increasingly being encountered in clinical practice. Herein, we describe one of the larger retrospective single institutional case series on ISCMs, analyze survival and treatment outcomes, and review the literature. All surgically evaluated ISCMs at our institution between 2005 and 2023 were retrospectively reviewed. Demographics, tumor features, treatment, and clinical outcome characteristics were collected. Neurological function was quantified via the Frankel grade and the McCormick score (MCS). The pre- and post-operative Karnofsky performance scores (KPS) were used to assess functional status. Descriptive statistics, univariate analysis, log-rank test, and the Kaplan–Meier survival analysis were performed. A total of 9 patients were included (median age 67 years (range, 26–71); 6 were male). Thoracic and cervical spinal segments were most affected (4 patients each). Six patients (75%) underwent surgical management (1 biopsy and 5 resections), and 3 cases underwent chemoradiation only. Post-operatively, 2 patients had an improvement in their neurological exam with one patient becoming ambulatory after surgery; three patients maintained their neurological exam, and 1 had a decline. There was no statistically significant difference in the pre- and post-operative MCS and median KPS scores in surgically treated patients. Median OS after ISCM diagnosis was 7 months. Absence of brain metastasis, tumor histology (renal and melanoma), cervical/thoracic location, and post-op KPS ≥ 70 showed a trend toward improved overall survival. The incidence of ISCM is increasing, and earlier diagnosis and treatment are considered key for the preservation of neurological function. When patient characteristics are favorable, surgical resection of ISCM can be considered in patients with rapidly progressive neurological deficits. Surgical treatment was not associated with an improvement in overall survival in patients with ISCMs.

surgery,clinical neurology
The surgical treatment of metastatic spine tumors within the intramedullary compartment

Ben A Strickland,Ian E McCutcheon,Indro Chakrabarti,Laurence D Rhines,Jeffrey S Weinberg

DOI: https://doi.org/10.3171/2017.5.SPINE161161

Abstract:OBJECTIVE Metastasis to the spinal cord is rare, and optimal management of this disease is unclear. The authors investigated this issue by analyzing the results of surgical treatment of spinal intramedullary metastasis (IM) at a major cancer center. METHODS The authors retrospectively reviewed the medical records of 13 patients who underwent surgery for IM. Patients had renal cell carcinoma (n = 4), breast carcinoma (n = 3), melanoma (n = 2), non-small cell lung cancer (n = 1), sarcoma (n = 1), adenoid cystic carcinoma (n = 1), and cervical cancer (n = 1). Cerebrospinal fluid was collected before surgery in 11 patients, and was negative for malignant cells, as was MRI of the neuraxis. Eleven patients presented with neurological function equivalent to Frankel Grade D. RESULTS Radiographic gross-total resection was achieved in 9 patients, and tumor eventually recurred locally in 3 of those 9 (33%). Leptomeningeal disease was diagnosed in 4 patients after surgery. In the immediate postoperative period, neurological function in 6 patients deteriorated to Frankel Grade C. At 2 months, only 2 patients remained at Grade C, 8 were at Grade D, and 1 had improved to Grade E. One patient developed postoperative hematoma resulting in Frankel Grade A. Radiotherapy was delivered in 8 patients postoperatively. The median survival after spine surgery was 6.5 months. Three patients are still living. CONCLUSIONS Surgery was performed as a last option to preserve neurological function in patients with IM. In most patients, neurological function returned during the immediate postoperative period and was preserved for the patients' remaining lifetime. The data suggest that surgery can be effective in preventing further decline in selected patients with progressive neurological deficit.
Thoracic Deformity (Tumor) Surgery Complications

William C. Newman,Nduka M. Amankulor

DOI: https://doi.org/10.1007/978-3-319-60083-3_17

2017-12-30

Abstract:As treatment regimens for primary cancer improve, patients are surviving longer and experiencing increased incidence of spinal column metastases. After the lungs and the liver, the skeletal system is the third most common site for metastases (Witham et al, Nat Clin Pract Neurol 2(2):87–94, 2006), with breast, lung, and prostate cancer accounting for greater than 50% of tumor origin sites (Metastatic Spinal Cord Compression: Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression. NICE Clinical Guidelines, No. 75. National Collaborating Centre for Cancer (UK). Cardiff (UK), 2008). The typical symptoms of spinal column metastases are pain, mechanical instability, and neurologic deficits. Surgical management of such lesions often requires circumferential decompression with instrumented fixation, followed by adjuvant radiation therapy to the affected levels.The preferred method for obtaining circumferential decompression and instrumented fusion varies by institution and surgeon, with some surgeons utilizing anterior transcavitary approaches, others using posterior/posterolateral approaches, and some using combined approaches. A major consideration when choosing these approaches should be their associated rates of hardware failure (i.e., screw haloing, screw pullout, rod fractures, and adjacent level fractures). Additionally, patient-specific factors such as morbidity, bone quality, and life expectancy may need to be taken into account when considering an appropriate approach for treating metastatic epidural spinal cord compression.In this chapter, we will discuss potential complications, complication avoidance strategies, and complication management techniques for patients who have undergone circumferential decompression and/or instrumented fusion for metastatic disease to the spinal column.
A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours

N. Atsu,S. Eskiçorapçı,A. Uner,S. Ekici,Y. Güngen,I. Erkan,M. Uygur,H. Özen

DOI: https://doi.org/10.1046/j.1464-410X.2003.04270.x

2003-07-01

BJU International

Abstract:To report the results of a novel surveillance policy for stage I nonseminomatous germ cell tumours (NSGCTs).
Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update

Ning Mao Kam,Julian Maingard,Hong Kuan Kok,Dinesh Ranatunga,Duncan Brooks,William C. Torreggiani,Peter L. Munk,Michael J. Lee,Ronil V. Chandra,Hamed Asadi

DOI: https://doi.org/10.1007/s11864-017-0516-7

2017-11-16

Current Treatment Options in Oncology

Abstract:Opinion statementSpinal metastases are the most commonly encountered tumour of the spine, occurring in up to 40% of patients with cancer. Each year, approximately 5% of cancer patients will develop spinal metastases. This number is expected to increase as the life expectancy of cancer patients increases. Patients with spinal metastases experience severe and frequently debilitating pain, which often decreases their remaining quality of life. With a median survival of less than 1 year, the goals of treatment in spinal metastases are reducing pain, improving or maintaining level of function and providing mechanical stability. Currently, conventional treatment strategies involve a combination of analgesics, bisphosphonates, radiotherapy and/or relatively extensive surgery. Despite these measures, pain management in patients with spinal metastases is often suboptimal. In the last two decades, minimally invasive percutaneous interventional radiology techniques such as vertebral augmentation and radiofrequency ablation (RFA) have shown progressive success in reducing pain and improving function in many patients with symptomatic spinal metastases. Both vertebral augmentation and RFA are increasingly being recognised as excellent alternative to medical and surgical management in carefully selected patients with spinal metastases, namely those with severe refractory pain limiting daily activities and stable pathological vertebral compression fractures. In addition, for more complicated lesions such as spinal metastasis with soft tissue extension, combined treatments such as vertebral augmentation in conjunction with RFA may be helpful. While combined RFA and vertebral augmentation have theoretical benefits, comparative trials have not been performed to establish superiority of combined therapy. We believe that a multidisciplinary approach as well as careful pre-procedure evaluation and imaging will be necessary for effective and safe management of spinal metastases. RFA and vertebral augmentation should be considered during early stages of the disease so as to maintain the remaining quality of life in this patient population group.

oncology
Metastatic spinal cord compression: the Spinal Instability Neoplastic Score and early surgical intervention

Petr Daniel Edward Kovarik,Ahmed Fadulelmola,Ahmed Hashmi,Charles Kelly,Nick West,Rahul Patil,Muhammad Shahid Iqbal

DOI: https://doi.org/10.1136/spcare-2023-004537

IF: 4.6332

2024-03-08

BMJ Supportive & Palliative Care

Abstract:Objectives To evaluate the value of Spinal Instability Neoplastic Score (SINS) in patients with spine metastasis who subsequently developed or did not develop metastatic spinal cord compression (MSCC). Methods In this single institutional retrospective descriptive observational study, of 589 patients with MSCC who were referred for radiotherapy, 34 patients (with 41 compression sites) met the inclusion criteria: availability of diagnostic MRI spine pre-development of MSCC (MRI-1) and at the time of MSCC development (MRI-2) (CordGroup). For comparison, NoCordGroup consisted of 152 patients (160 sites) treated with radiotherapy to spinal metastases. SINS was compared between the two groups. Results In CordGroup, the median interval between MRI-1 and MRI-2 was 11 weeks. The median SINS was 8 (range: 4–14) and 9 (range: 7–14) on MRI-1 and MRI-2, respectively. In NoCordGroup, the median SINS was 6 (range: 4–10). Conclusions Our study showed a trend in difference in SINS value between the two groups. This difference should be a subject of future prospective research in this patient population with poor survival.

health care sciences & services
Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes

Amr Badary,Ahmed Kertam,Toka Aziz El-Ramly,Noura E Abomera,Esraa Y Salama,Sondous Abdelaal,Fatma Monib,Alan Hernández-Hernández,Vivik Sanker,Oday Atallah,Wahab Moustafa,Jörg Silbermann,Mohammad Khalil Al-Barbarawi

DOI: https://doi.org/10.1007/s11060-024-04816-x

2024-08-30

Abstract:Introduction: Metastasis to the conus medullaris (CM) is a rare but devastating condition. This systematic review aimed to evaluate the clinical presentation, diagnostic workup, treatment options, and outcomes of patients with CM metastasis. By synthesizing the available evidence, this study seeks to improve our understanding of this condition and inform clinical practice. Materials and methods: A systematic review adhering to PRISMA guidelines analyzed literature on CM metastasis from 1997 to January 2024. Human studies in English were included, focusing on primary research articles. Screening criteria ensured a homogeneous study population, with data analyzed using SPSS 26 and assessed for quality using the JBI checklist. Results: The study analyzed 88 patients with conus medullaris metastasis. Common symptoms included back pain (49.3%), sensory impairment (75%), and bladder dysfunction (60.3%). MRI was the primary diagnostic tool, revealing lesions above L1 (37%) or between L1 and L2 (29%). Treatment involved surgery with laminectomy, and combined therapy (surgery plus radiotherapy) in 81.3%. Postoperative outcomes showed improved motor function in 59.6% of patients, while combined therapy yielded better sensory and bowel/bladder function recovery. Median survival was 100 days. Conclusion: Metastasis to the conus medullaris is rare but significant. Surgical resection can improve motor function, while combined therapy (surgery plus radiotherapy) is effective in improving sensory manifestations and bowel/bladder functions. Despite these treatments, the median survival remains around 100 days, which is shorter compared to other types of intramedullary spinal cord metastases.
Spinal cord stimulation may reduce lumbar radiculopathy in the setting of metastatic colon cancer

Harman Chopra,Melissa Jackels,Arvind Senthil Kumar,Mustafa Broachwala,Tariq AlFarra,Joel Castellanos

DOI: https://doi.org/10.1016/j.inpm.2023.100374

2023-12-15

Abstract:Cancer pain has a substantial impact on the quality of life and functional capacity with a prevalence of up to 70 % in patients with advanced, metastatic, or terminal disease [1]. The WHO pain ladder has been used in practice to guide cancer pain management. A three-step ladder starts with NSAIDs and non-opioids for mild pain, weak opioids for mild to moderate pain and strong opioids for moderate to severe pain with the use of adjuvant medications such as TCAs and muscle relaxants at any stage for optimization (Fallon et al., Dec 2022) [2] We present a case of a patient with metastatic colon cancer who was admitted for intractable pain crisis and right sided L-5 radiculopathy secondary to epidural metastasis (Figs. 1 and 2). The patient's pain left her bedridden, unable to walk and remained refractory to an escalating intravenous opioid regimen and caudal epidural steroids. The patient subsequently underwent spinal cord stimulation (SCS) trial at level T-7 and achieved >80 % pain relief resulting in a markedly decreased opioid requirement and tremendous recovery of ambulatory function (Fig. 3). After sustained results, a permanent implant was placed at T-8 and patient remains discharged with functional restoration and continued pain improvement (Fig. 4). To our knowledge, this is a novel application of SCS for a refractory pain crisis secondary to a metastatic colon cancer induced radiculopathy presenting with severe functional impairment. As we transition away from opioid use, it is imperative as pain physicians, to investigate the potential of current as an alternative means of cancer pain management: a ubiquitous and challenging clinical conundrum.
Surgical Outcomes and Prognostic Factors in Patients With Diffuse Large B-cell Lymphoma-associated Metastatic Spinal Cord Compression.

Shuai Han,Xinghai Yang,Dongjie Jiang,Wang Zhou,Tielong Liu,Wangjun Yan,Ting Wang,Li Cheng,Jianru Xiao

DOI: https://doi.org/10.1097/BRS.0000000000001511

IF: 3.241

2016-01-01

Spine

Abstract:Study Design. A retrospective study. Objective. The aim of this study was to discuss the factors that may affect surgical outcomes of patient with diffuse large B-cell lymphoma (DLBCL)-associated metastatic spinal cord compression (MSCC). Summary of Background Data. DLBCL in the spine is rare and minimal information has been published in the literature regarding this subject. Although DLBCL is highly sensitive to both chemotherapy and radiotherapy, surgical decompression is recommended in the treatment of DLBCL-associated MSCC. However, the prognostic factors affecting surgical outcomes of patients with DLBCL-associated MSCC remain unknown. Methods. We conducted a retrospective study to investigate the impact of surgical decompression on recovery from neurological deficit caused by DLBCL-associated MSCC. Univariate and multivariate analyses were performed to identify prognostic factors for overall survival of spinal DLBCL. The survival rate was estimated by the Kaplan-Meier method, and differences were analyzed by the log-rank test. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis. Results. A total of 37 patients with spinal DLBCL from 2003 to 2014 were included in the study. International Prognostic Index (IPI) (0-1/2-5), duration of preoperative symptoms (<= 2m/>2m), and lactate dehydrogenase (normal/abnormal) were suggested as the potential prognostic factors through univariate analysis. However, as they were submitted to the multivariate Cox regression model, only IPI and duration of preoperative symptoms were found as independent prognostic factors. Conclusion. Surgical decompression improves recovery from neurological deficit. Patient IPI score plays an important role in decision making for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.

Diagnostischer Standard bei chronisch entzündlichen Darmerkrankungen

Narrative review-diagnosing and managing malignant epidural spinal cord compression: an evidence-based approach

Non-gravitational forces and masses of some long-period comets. The cases of Hale-Bopp and Hyakutake

Advances in Imaging for Metastatic Epidural Spinal Cord Compression: A Comprehensive Review of Detection, Diagnosis, and Treatment Planning

Surgical Management and Outcomes of Spinal Metastasis of Malignant Adrenal Tumor: A Retrospective Study of Six Cases and Literature Review

Approaches to radiotherapy in metastatic spinal cord compression

Evaluating the impact of the metastatic spinal cord compression coordinator in a regional cancer network: a prospective, non-randomized pilot study

Challenge or opportunity: Rehabilitation outcomes in patients with metastatic spinal cord compression – a UK single center experience

Surgery in Acute Metastatic Spinal Cord Compression: Timing and Functional Outcome

Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases

Diagnostic Accuracy of CT for Metastatic Epidural Spinal Cord Compression

Die dynamische Pyramide zur 3D-Rekonstruktion von Bildpaaren

Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature

The surgical treatment of metastatic spine tumors within the intramedullary compartment

Thoracic Deformity (Tumor) Surgery Complications

A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours

Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update

Metastatic spinal cord compression: the Spinal Instability Neoplastic Score and early surgical intervention

Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes

Spinal cord stimulation may reduce lumbar radiculopathy in the setting of metastatic colon cancer

Surgical Outcomes and Prognostic Factors in Patients With Diffuse Large B-cell Lymphoma-associated Metastatic Spinal Cord Compression.